The core targets of Hedyotis diffusa in treating cervical cancer mainly included AKT1, VEGFA, TNF, IL6, PTGS2, JUN, IL1B, CASP3, MAPK3, and MMP9. Here, PTGS2 is linked to cervical cancer.